Literature DB >> 6103676

A study of antipsychotic drug use in nursing homes: epidemiologic evidence suggesting misuse.

W A Ray, C F Federspiel, W Schaffner.   

Abstract

We reviewed 384,326 prescriptions for 5,902 Medicaid patients residing continuously for one year in 173 Tennessee nursing homes. Of these patients, 43 per cent received antipsychotic drugs; 9 per cent were chronic recipients (received at least 365 daily doses per year). Of the 1,580 physicians who cared for these patients, 42 per cent prescribed antipsychotic medication. Physicians with large nursing home practices (10 or more patients) prescribed 81 per cent of the total antipsychotic medication, and were usually family practitioners (78 per cent) and in rural practice (47 per cent). As nursing home practice size increased, doctors prescribed more drug per patient (p less than .001). Wide variation in antipsychotic drug use occurred among nursing homes; the chronic recipient rate ranged from 0 to 46 per cent. More drug was given per patient in larger homes (r = .18, p less than .05). Typically, one physician (the "dominant" physician) provided care for the majority of a nursing home's patients. The proportion of a home's patients seen by the dominant physician was correlated with the chronic recipient rate (r = .17, p less than .05). These findings provide epidemiologic evidence suggesting misuse of antipsychotic drugs in nursing homes. They illustrate the need for investigations of techniques for patient management in nursing homes which rely less upon psychtropic drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6103676      PMCID: PMC1619409          DOI: 10.2105/ajph.70.5.485

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  13 in total

1.  Drug therapy of tardive dyskinesia.

Authors:  R M Kobayashi
Journal:  N Engl J Med       Date:  1977-02-03       Impact factor: 91.245

2.  Observations on the psychopharmacology of the aged.

Authors:  C Eisdorfer
Journal:  J Am Geriatr Soc       Date:  1975-02       Impact factor: 5.562

3.  Epidemiology of tardive dyskinesia Part I.

Authors:  R Pineau; R Lachance; G Pelchat; K Jus; P Pires; P Pires
Journal:  Dis Nerv Syst       Date:  1976-04

4.  Management of emotional disturbances in geriatric patients.

Authors:  A S Maurer
Journal:  J Am Geriatr Soc       Date:  1973-05       Impact factor: 5.562

5.  Psychotropic drugs and the elderly patient.

Authors:  B M Learoyd
Journal:  Med J Aust       Date:  1972-05-27       Impact factor: 7.738

6.  Is good nursing-home care feasible?

Authors:  R L Kane; L A Jorgensen; B Teteberg; J Kuwahara
Journal:  JAMA       Date:  1976-02-02       Impact factor: 56.272

7.  Medicaid records as a valid data source: the Tennessee experience.

Authors:  C F Federspiel; W A Ray; W Schaffner
Journal:  Med Care       Date:  1976-02       Impact factor: 2.983

8.  The use of psychoactive drugs in elderly patients with psychiatric disorders: survey conducted in twelve Veterans Administration hospitals.

Authors:  R F Prien; P A Haber; E M Caffey
Journal:  J Am Geriatr Soc       Date:  1975-03       Impact factor: 5.562

9.  A survey of the prescribing and administration of drugs in a long-term care institution for the elderly.

Authors:  S R Ingman; I R Lawson; P G Pierpaoli; P Blake
Journal:  J Am Geriatr Soc       Date:  1975-07       Impact factor: 5.562

10.  The use of mechanical and chemical restraints in nursing homes.

Authors:  A B Covert; T Rodrigues; K Solomon
Journal:  J Am Geriatr Soc       Date:  1977-02       Impact factor: 5.562

View more
  35 in total

1.  Impact of legislation on nursing home care in the United States: lessons for the United Kingdom.

Authors:  C M Hughes; K L Lapane; V Mor
Journal:  BMJ       Date:  1999-10-16

Review 2.  Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes: how successful have they been?

Authors:  Carmel M Hughes; Kate L Lapane
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 3.  Medical care of the elderly in the nursing home.

Authors:  P Starer; L S Libow
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

Review 4.  Hypnotics in the elderly. What cause for concern?

Authors:  K Morgan
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Drug use in Swedish nursing homes.

Authors:  C B Claesson; I K Schmidt
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

6.  Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients.

Authors:  H J Kopecky; C R Kopecky; S C Yudofsky
Journal:  Psychiatr Q       Date:  1998

Review 7.  Deprescribing in Older Nursing Home Patients: Focus on Innovative Composite Measures for Dosage Deintensification.

Authors:  Sherrie L Aspinall; Joseph T Hanlon; Joshua D Niznik; Sydney P Springer; Carolyn T Thorpe
Journal:  Innov Aging       Date:  2017-12-20

Review 8.  New atypical antipsychotics. Experience and utility in the elderly.

Authors:  R A Sweet; B G Pollock
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

Review 9.  Drug dosage in the elderly. Is it rational?

Authors:  K Turnheim
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 10.  Institutionalisation and drug use in older adults in the US.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.